These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8423547)

  • 21. Minimal effect of acute experimental hepatitis induced by lipopolysaccharide/D-galactosamine on biotransformation in rats.
    Omar H el-D ; Sanders RA; Watkins JB
    Biochem Pharmacol; 1996 Dec; 52(12):1921-4. PubMed ID: 8951352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactulose--a drug with antiendotoxin effect.
    Liehr H; Englisch G; Rasenack U
    Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The limiting effect of dichloroacetate on endotoxin-induced liver damage in starved rats.
    Irita K; Okabe H; Koga A; Yamakawa M; Yoshitake J
    J Surg Res; 1994 Mar; 56(3):216-20. PubMed ID: 8145537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure.
    Nakao A; Taki S; Yasui M; Kimura Y; Nonami T; Harada A; Takagi H
    Hepatology; 1994 May; 19(5):1251-6. PubMed ID: 8175149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Cuban red propolis on galactosamine-induced hepatitis in rats.
    Rodríguez S; Ancheta O; Ramos ME; Remírez D; Rojas E; González R
    Pharmacol Res; 1997 Jan; 35(1):1-4. PubMed ID: 9149308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells.
    Stachlewitz RF; Seabra V; Bradford B; Bradham CA; Rusyn I; Germolec D; Thurman RG
    Hepatology; 1999 Mar; 29(3):737-45. PubMed ID: 10051475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of a novel quinone derivative, E3330, on mouse hepatitis virus (MHV)-induced chronic hepatitis in athymic nude mice.
    Uetsuka K; Suzuki M; Kai C; Goto N
    Exp Anim; 1997 Jul; 46(3):219-23. PubMed ID: 9250483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin.
    Mihas AA; Ceballos R; Mihas TA; Hirschowitz BI
    J Med; 1990; 21(6):301-11. PubMed ID: 2093097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Tiegs G; Wolter M; Wendel A
    Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat.
    James GW; Pickering RW
    Arzneimittelforschung; 1976; 26(12):2197-9. PubMed ID: 1037274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protective effect of a platelet activating factor antagonist in experimental liver injury].
    Zhang F
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):375-8, 26. PubMed ID: 2171727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion.
    Liu P; Fisher MA; Farhood A; Smith CW; Jaeschke H
    Circ Shock; 1994 Jun; 43(2):64-70. PubMed ID: 7834822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galactosamine-induced sensitization to the lethal effects of endotoxin.
    Galanos C; Freudenberg MA; Reutter W
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5939-43. PubMed ID: 293694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G; Werner C
    Biochem Pharmacol; 1987 Aug; 36(16):2637-9. PubMed ID: 3606663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective effects of fibronectin in galactosamine-induced liver failure in rats.
    Moriyama T; Aoyama H; Ohnishi S; Imawari M
    Hepatology; 1986; 6(6):1334-9. PubMed ID: 3793010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats.
    Jaeschke H; Farhood A; Smith CW
    Hepatology; 1994 Apr; 19(4):973-9. PubMed ID: 8138272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.